Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.

Stefano ConsoliFedele DonoGiacomo EvangelistaMaria D'ApolitoDaniela TravagliniMarco OnofrjLaura Bonanni

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)

In patients with a history of migraine, COVID-19 vaccination could lead to a worsening of headache and, in rare cases, to the development of a SMg. This may be related to the inflammatory response that occurs after vaccination.

Keyphrases

coronavirus disease
sars cov
inflammatory response
respiratory syndrome coronavirus
lipopolysaccharide induced
emergency department
toll like receptor
risk assessment
human health
climate change